Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find Deucrictibant manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Deucrictibant
Also known as: Deucrictibant [inn], 69gca2kx22, Pha-121, Unii-69gca2kx22, Phvs-719, Pha-022121
Molecular Formula
C25H23ClF3N5O3
Molecular Weight
534.9  g/mol
InChI Key
ZTCLCSCHTACERP-WTDRUJNCSA-N
FDA UNII
69GCA2KX22

1 2D Structure

Deucrictibant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(1S)-1-[3-chloro-5-fluoro-2-[[2-methyl-4-(2-methyl-1,2,4-triazol-3-yl)quinolin-8-yl]oxymethyl]phenyl]-1-deuterioethyl]-2-(difluoromethoxy)acetamide
2.1.2 InChI
InChI=1S/C25H23ClF3N5O3/c1-13-7-18(24-30-12-31-34(24)3)16-5-4-6-21(23(16)32-13)36-10-19-17(8-15(27)9-20(19)26)14(2)33-22(35)11-37-25(28)29/h4-9,12,14,25H,10-11H2,1-3H3,(H,33,35)/t14-/m0/s1/i14D
2.1.3 InChI Key
ZTCLCSCHTACERP-WTDRUJNCSA-N
2.1.4 Canonical SMILES
CC1=CC(=C2C=CC=C(C2=N1)OCC3=C(C=C(C=C3Cl)F)C(C)NC(=O)COC(F)F)C4=NC=NN4C
2.1.5 Isomeric SMILES
[2H][C@](C)(C1=C(C(=CC(=C1)F)Cl)COC2=CC=CC3=C(C=C(N=C32)C)C4=NC=NN4C)NC(=O)COC(F)F
2.2 Other Identifiers
2.2.1 UNII
69GCA2KX22
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Deucrictibant [inn]

2. 69gca2kx22

3. Pha-121

4. Unii-69gca2kx22

5. Phvs-719

6. Pha-022121

7. 2340111-58-0

8. (s)-n-(1-deutero-1-(3-chloro-5-fluoro-2-((2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)quinolin-8-yloxy)methyl)phenyl)ethyl)-2-(difluoromethoxy)acetamide

9. Acetamide, N-((1s)-1-(3-chloro-5-fluoro-2-(((2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)-8-quinolinyl)oxy)methyl)phenyl)ethyl-1-d)-2-(difluoromethoxy)-

10. Chembl5095059

11. Schembl22320140

12. Gtpl12421

13. Glxc-26832

14. Pha022121

15. Hy-145562

16. Cs-0376051

17. N-[(1s)-1-[3-chloro-5-fluoro-2-({[2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)quinolin-8-yl]oxy}methyl)phenyl](1-2h)ethyl]-2-(difluoromethoxy)acetamide

18. N-[(1s)-1-[3-chloro-5-fluoro-2-[[2-methyl-4-(2-methyl-1,2,4-triazol-3-yl)quinolin-8-yl]oxymethyl]phenyl]-1-deuterioethyl]-2-(difluoromethoxy)acetamide

2.4 Create Date
2020-09-28
3 Chemical and Physical Properties
Molecular Weight 534.9 g/mol
Molecular Formula C25H23ClF3N5O3
XLogP34.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area91.2
Heavy Atom Count37
Formal Charge0
Complexity758
Isotope Atom Count1
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY